- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01734980
Endobronchial Ultrasound Transbronchial Needle Aspiration Using Needle Suction Versus No Suction
Comparison Of Cytologic Accuracy Of Endobronchial Ultrasound Transbronchial Needle Aspiration Using Needle Suction Versus No Suction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Endobronchial ultrasound-guided transbronchial needle aspiration which is known as the EBUS procedure is a low risk procedure performed using bronchoscopy to sample chest lesions. A needle is passed through the bronchoscope to biopsy the chest lesion. Every lesion is usually biopsied 3 to 7 times. In most cases the investigators apply a syringe with negative pressure to the needle inserted into lesion for biopsy. In some cases the investigators don't apply any negative pressure. There are no studies to evaluate which one is better, applying syringe suction or no suction.
In our study, the investigators are planning to do biopsies with or without suction. Then, the pathology samples will be evaluated for any cytologic difference in making the diagnosis. Any patient undergoing the EBUS procedure for chest biopsies will be eligible. Every lesion will be biopsied at least twice with needle with and without suction. The biopsy samples will be then divided into group A where the investigators applied syringe suction and group B where no syringe suction was applied. There is no risk to the patient in addition to the risk of the EBUS procedure itself. The investigators are not performing any additional intervention from the usual standard of care for any patient presenting for the EBUS procedure. Essentially the investigators are simply grouping the suction and no suction pathology samples as A and B for pathologic comparison.
RESULTS: Among the 26 participants, one of the patients (3.8%) had no adequate tissue using both methods; one patient (3.8%) had adequate tissue using suction but no adequate tissue using no suction; and 24 patients had adequate tissue using both methods (92.3%, p= 1.00). Among the twenty-four patients with adequate tissue using both methods, 14 patients (58.3%) had benign pathology using both methods, while ten patients (41.7%) had malignant pathology using both methods (p= 1.00). Considering suction to be the golden method, the sensitivity and specificity of no suction were 100%. Among the 32 sites that were sampled, one site (3.1%) had no adequate tissue using both methods; one site (3.1%) had adequate tissue using suction but no adequate tissue using no suction; and 30 sites had adequate tissue using both methods (93.8%, p= 1.00). Among the thirty sites with adequate tissue using both methods, 17 (56.7%) had benign pathology using both methods; 12 (40.0%) had malignant pathology using both methods; and one site (3.3%) had malignant pathology using suction, but benign pathology using no suction (p= 1.00). Considering suction to be the golden method, the no suction had a sensitivity= 92.3% and specificity= 100%.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Staten Island, New York, United States, 10305
- Staten Island University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All adult subjects who are scheduled to undergo endobronchial ultrasound transbronchial aspiration to sample mediastinal masses or lymph nodes.
Exclusion Criteria:
- Patients who are not able to complete the EBUS procedure for any reason
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Endobronchial Ultrasound
EBUS-TBNA is a procedure that allows accurate sampling of mediastinal lymph nodes and peribronchial lesions
|
The samples will be divided as 2 groups for comparison.
Group A is the group of samples where we apply negative pressure syringe for needle suction.
Group B is where no suction will be applied after needle insertion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic yield
Time Frame: 3 days
|
The number of patients with cytological diagnosis as a measure of effective diagnostic technique.
|
3 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Samples adequacy
Time Frame: 3 days
|
adequate cytological material as a measure of effective diagnostic technique.
|
3 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11-018 (CTC-A)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mediastinal Lymphadenopathy
-
China-Japan Friendship HospitalNot yet recruitingLymphadenopathy Hilar | Lymphadenopathy Mediastinal
-
Sanjay Gandhi Postgraduate Institute of Medical...CompletedMediastinal Lymphadenopathy | Hilar LymphadenopathyIndia
-
China-Japan Friendship HospitalRecruitingStudy on Transbronchial Ultrasound-guided Cryobiopsy in the Diagnosis of Mediastinal LymphadenopathyMediastinal LymphadenopathyChina
-
National Taiwan University HospitalUnknown
-
Third Military Medical UniversityHeidelberg UniversityCompletedMediastinal LymphadenopathyChina, Germany
-
Royal Brompton & Harefield NHS Foundation TrustUnknown
-
Hannover Medical SchoolUnknown
-
Baylor College of MedicineCompletedMediastinal Lymphadenopathies | Mediastinal Masses | Hilar LymphadenopathiesUnited States
-
National Taiwan University HospitalUnknownMediastinal Lymphadenopathy | Tuberculous Mediastinal LymphadenopathyTaiwan
-
Chang Gung Memorial HospitalUnknownLung Cancer | Mediastinal LymphadenopathyTaiwan
Clinical Trials on Endobronchial Ultrasound
-
Johns Hopkins UniversityCompleted
-
Samsung Medical CenterUnknownComplication | UltrasoundKorea, Republic of
-
Chang Gung Memorial HospitalUnknown
-
Institut universitaire de cardiologie et de pneumologie...Not yet recruitingLung Cancer | Non Small Cell Lung Cancer | Circulating Tumor Cell
-
Haukeland University HospitalHelse Sunnmore, 6026 ÅlesundCompleted
-
Chinese PLA General HospitalUnknown
-
St. Joseph's Healthcare HamiltonCompletedLung Diseases | Lung NeoplasmCanada
-
Jiayuan SunRecruitingLymph Node DiseaseChina
-
Samsung Medical CenterCompletedCarcinoma, Non-Small Cell LungKorea, Republic of
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting